問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2012-05-01 - 2014-05-31
Condition/Disease
SYSTEMIC LUPUS ERYTHEMATOSUS
Test Drug
PF-04236921 Powder for Injection, 106 mg/vial
Participate Sites4Sites
Terminated3Sites
Study ended1Sites
2012-05-12 - 2015-05-31
Participate Sites8Sites
Terminated8Sites
2012-02-01 - 2016-12-31
Participate Sites5Sites
Terminated5Sites
2011-10-01 - 2012-11-30
Participate Sites12Sites
Terminated12Sites
2011-08-01 - 2014-12-31
2010-06-30 - 2015-03-31
Participate Sites11Sites
Terminated11Sites
2012-08-02 - 2013-06-25
Participate Sites17Sites
Terminated17Sites
2012-06-27 - 2013-09-09
Participate Sites2Sites
Terminated2Sites
2012-09-01 - 2016-02-28
Schizophrenia
SM-13496
Division of Psychiatry
2012-08-01 - 2015-08-31
schizophrenia
Participate Sites13Sites
Terminated13Sites
全部
